Insider Transactions in Q4 2025 at Ani Pharmaceuticals Inc (ANIP)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 18
2025
|
Krista Davis SVP, CHIEF HR OFFICER |
SELL
Open market or private sale
|
Direct |
1,622
-2.7%
|
$133,004
$82.4 P/Share
|
|
Dec 12
2025
|
Meredith Cook SR. VP, GENERAL COUNSEL & SEC. |
SELL
Open market or private sale
|
Direct |
400
-0.53%
|
$32,800
$82.32 P/Share
|
|
Dec 05
2025
|
Renee P Tannenbaum Director |
SELL
Open market or private sale
|
Direct |
1,800
-6.68%
|
$145,800
$81.15 P/Share
|
|
Nov 13
2025
|
Patrick D Walsh Director |
SELL
Bona fide gift
|
Direct |
3,000
-4.89%
|
-
|
|
Nov 13
2025
|
Patrick D Walsh Director |
SELL
Open market or private sale
|
Direct |
8,643
-12.34%
|
$743,298
$86.88 P/Share
|
|
Nov 13
2025
|
Chad Gassert SVP - CORP. DEV. & STRATEGY |
SELL
Open market or private sale
|
Indirect |
94
-0.06%
|
$8,272
$88.0 P/Share
|
|
Nov 13
2025
|
Meredith Cook SR. VP, GENERAL COUNSEL & SEC. |
SELL
Open market or private sale
|
Direct |
400
-0.53%
|
$34,800
$87.27 P/Share
|
|
Nov 12
2025
|
Chad Gassert SVP - CORP. DEV. & STRATEGY |
SELL
Open market or private sale
|
Indirect |
14,642
-8.45%
|
$1,303,138
$89.07 P/Share
|
|
Oct 13
2025
|
Meredith Cook SR. VP, GENERAL COUNSEL & SEC. |
SELL
Open market or private sale
|
Direct |
400
-0.53%
|
$36,000
$90.09 P/Share
|